Author:
Schimpf Kl.,Barth P.,Wüstemann A. -M.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Genetics(clinical),Drug Discovery,Molecular Medicine
Reference10 articles.
1. Alkjaersig, N., A.-P. Fletsher, andS. Sherry: Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. II. The significance, mechanism and consequences of defective fibrin polymerization. J. clin. Invest.41, 917–934 (1962).
2. Bachmann, F., F. Duckert, M. Geiger, P. Baer, andF. Koller: Differentiation of the factor VII complex. Studies on the Stuart-Prower-factor. Thrombos. Diathes. haemorrh. (Stuttg.)1, 169–194 (1957).
3. Jung, E. G.: A rapid quantitative assay of factor VIII (AHG) without the use of hemophilia A plasma. Thrombos. Diathes. haemorrh. (Stuttg.)4, 323–330 (1960).
4. Niewiarowski, S., andE. Kowalski: Antithrombin formation during proteolysis of fibrinogen. Trans. 6th Congr. Europ. Soc. Haematol., Copenhagen, S. 560 (1957).
5. —— ——: Un nouvel anticoagulant dérivée du fibrinogène. Rev. Hémat.13, 320–328 (1958).